Cervical DNA Dtex® Test
NeoDiagnostix
NeoNet »
NeoDiagnostix is a cancer diagnostics company with an emphasis in women's health. We are dedicated to providing physicians with more accurate and timely information that will lead to better patient care decisions.    >> Learn More
How It Works
The Cervical DNA Dtex Test identifies the irreversible DNA damage* to cervical cells.

> Cervical DNA Dtex Case Studies
  The Cervical DNA Dtex Test identifies the irreversible DNA damage* to cervical cells.
  


REQUEST INFORMATION

Name *  
Email *  
Phone  
Message *  
*   Fields required
News & Updates

NeoDiagnositx, Inc. Announces issuance of Expanded US Patent Portfolio
October 22, 2014
NeoDiagnostix announced that the United States Patent and Trademark Office has granted two new patents owned by the company (US Patent No. 8,748,099 and 8,852,865) covering the detection of chromosomal abnormalities in cervical samples. The recently issued patents cover methods for identifying chromosomal abnormalities at multiple sites of the genome, including loci 3q, 5p, 20q and/or 1q, in a plurality of cells from a cervical sample.

NeoDiagnostix Inc. Announces Issuance of Third US Patent
June 12, 2014
NeoDiagnostix, Inc. announced that the United States Patent and Trademark Office has issued US Patent No. 8,748,099 covering the detection of chromosomal abnormalities in cervical samples. The patent covers methods for enumerating chromosomal copy number at location 3q, as well as other loci in the genome of cells from cervical samples.

NeoDiagnostix, Inc.    © 2014.    All rights reserved.     Website by Clark Concepts, LLC
NeoDiagnostix, Inc.
9 West Watkins Mill Road
Gaithersburg, MD 20878
Tel: 240-821-6000
Contact Us

References:
* as defined by multiple copies of 3q26 and/or 5p15 in cervical cells